» Articles » PMID: 20063164

Thulium Laser Enucleation of the Prostate (ThuLEP): Transurethral Anatomical Prostatectomy with Laser Support. Introduction of a Novel Technique for the Treatment of Benign Prostatic Obstruction

Overview
Journal World J Urol
Specialty Urology
Date 2010 Jan 12
PMID 20063164
Citations 88
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Transurethral removal of prostatic tissue is the treatment choice for benign prostatic enlargement and benign prostatic obstruction. Urodynamic results are directly linked to the amount of removed tissue which, however, is directly associated with intra- and postoperative morbidity. Transurethral laser operations of the prostate offer the advantage of decreased bleeding complications and the possibility to treat patients with bleeding disorders or anticoagulative treatment. The aim of the article is to present a novel technique of complete transurethral removal of the transition zone (enucleation) with the support of the Thulium laser to combine complete anatomical enucleation and maximum urodynamic efficacy with minimal side-effects.

Materials And Methods: We present five distinct surgical steps for transurethral complete removal of the transition zone of the prostate (Thulium laser enucleation of the prostate, ThuLEP). Surgical steps are presented in chronological order with the help of intraoperative pictures. Laser energy of 70-90 W is only used for the incision at the verumontanum and bladder neck for removal of the middle lobe, whereas laser energy of 30 W was only used for coagulation of small vessel crossing the surgical capsule towards the transition zone and bladder neck for dissection of the lateral lobes. The lobes themselves are liberated by blunt dissection.

Conclusions: ThuLEP offers complete removal of the transition zone no matter what prostatic size. The techniques combine maximum efficacy with minimal side-effects. Clinical results comparing ThuLEP with open prostatectomy or transurethral resection are awaited.

Citing Articles

Holmium: YAG laser enucleation of the prostate using the new cyber Ho generator with magneto technology: does it provide any advantages compared to thulium: YAG prostate enucleation?.

Perri D, Besana U, Mazzoleni F, Pacchetti A, Calcagnile T, Maltagliati M World J Urol. 2025; 43(1):161.

PMID: 40067530 DOI: 10.1007/s00345-025-05536-1.


Application trends and research hotspots of endoscopic enucleation of the prostate: a bibliometric and visualization analysis.

Lan X, Yu Z, Jiang R, Li Z, Yang L, Zhang K World J Urol. 2025; 43(1):140.

PMID: 40009250 DOI: 10.1007/s00345-024-05379-2.


Comparing surgical techniques: ThuLEP and transurethral BPEP for prostate over 80 grams. Intraoperative and postoperative results. A prospective randomized trial.

Morsy S, Elfeky M, Abdel-Rahman S, Torad H, Rammah A, Safwat M Arab J Urol. 2025; 23(1):1-7.

PMID: 39776558 PMC: 11703526. DOI: 10.1080/20905998.2024.2395594.


Thulium laser-based hemostasis during percutaneous nephrolithotomy: a prospective observational multicentric study.

Assem A, Elaziz I, Ashmawy A, Rammah A, Zamel A, Elkady A Int Urol Nephrol. 2024; .

PMID: 39704925 DOI: 10.1007/s11255-024-04298-w.


Urethral Strictures After Endoscopic Enucleation of the Prostate and Its Associated Clinical Outcomes in Aging Men.

Hou C, Wu J, Weng S, Lin Y, Chen C, Tsai H Medicina (Kaunas). 2024; 60(11).

PMID: 39596956 PMC: 11596730. DOI: 10.3390/medicina60111771.


References
1.
Te A, Malloy T, Stein B, Ulchaker J, Nseyo U, Hai M . Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multicenter prospective trial. J Urol. 2004; 172(4 Pt 1):1404-8. DOI: 10.1097/01.ju.0000139541.68542.f6. View

2.
Fu W, Hong B, Yang Y, Zhang X, Gao J, Zhang L . Vaporesection for managing benign prostatic hyperplasia using a 2-microm continuous-wave laser: a prospective trial with 1-year follow-up. BJU Int. 2008; 103(3):352-6. DOI: 10.1111/j.1464-410X.2008.08040.x. View

3.
Bach T, Huck N, Wezel F, Hacker A, Gross A, Michel M . 70 vs 120 W thulium:yttrium-aluminium-garnet 2 microm continuous-wave laser for the treatment of benign prostatic hyperplasia: a systematic ex-vivo evaluation. BJU Int. 2009; 106(3):368-72. DOI: 10.1111/j.1464-410X.2009.09059.x. View

4.
Elmansy H, Elzayat E, Sampalis J, Elhilali M . Prostatic-specific antigen velocity after holmium laser enucleation of the prostate: possible predictor for the assessment of treatment effect durability for benign prostatic hyperplasia and detection of malignancy. Urology. 2009; 74(5):1105-10. DOI: 10.1016/j.urology.2009.06.039. View

5.
Bach T, Herrmann T, Cellarius C, Gross A . Bladder neck incision using a 70 W 2 micron continuous wave laser (RevoLix). World J Urol. 2007; 25(3):263-7. DOI: 10.1007/s00345-007-0169-4. View